1. Home
  2. XXII vs CMND Comparison

XXII vs CMND Comparison

Compare XXII & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$1.04

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$0.12

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XXII
CMND
Founded
1998
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XXII
CMND
Price
$1.04
$0.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
190.3K
37.7M
Earning Date
11-04-2025
01-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$136.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.98
N/A
52 Week Low
$0.78
$0.10
52 Week High
$294.98
$2.18

Technical Indicators

Market Signals
Indicator
XXII
CMND
Relative Strength Index (RSI) 47.06 16.70
Support Level $0.98 $0.10
Resistance Level $1.09 $0.13
Average True Range (ATR) 0.09 0.04
MACD 0.04 0.01
Stochastic Oscillator 83.36 7.87

Price Performance

Historical Comparison
XXII
CMND

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: